List of insiders holdings for SpringWorks Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | GORDON CARL L Director 10% Owner |
2019-09-12 16:28:35 | 0 7,131,307 |
7,131,307 | Form 3 |
| 2 | SQUINTO STEPHEN P Director 10% Owner |
2022-05-20 17:44:52 | 146,970 6,186,307 |
6,333,277 | Form 4 |
| 3 | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
2023-12-06 16:43:33 | 3,567,159 0 |
3,567,159 | Form 13D |
| 4 | Schwartz Jeffrey Lawrence Director |
2023-05-25 17:04:48 | 24,346 3,081,307 |
3,105,653 | Form 4 |
| 5 | Bain Capital Life Sciences Investors LLC BC SW LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner |
2023-03-20 17:01:57 | 3,081,307 0 |
3,081,307 | Form 13D |
| 6 | PFIZER INC Pfizer Ventures (US) LLC 10% Owner |
2022-02-11 19:01:39 | 2,340,330 0 |
2,340,330 | Form 13G |
| 7 | Islam Saqib Chief Executive Officer |
2025-03-05 18:32:29 | 954,869 0 |
954,869 | Form 4 |
| 8 | Renstrup Jens Chief Medical Officer |
2021-01-11 09:30:41 | 299,099 0 |
299,099 | Form 4 |
| 9 | Smith L. Mary Chief Development Officer |
2024-01-08 21:13:06 | 293,363 0 |
293,363 | Form 4 |
| 10 | Greco Michael V. General Counsel & Secretary |
2019-09-12 16:29:46 | 246,975 0 |
246,975 | Form 3 |
| 11 | Edris Badreddin Chief Operating Officer |
2025-03-05 18:33:49 | 169,712 0 |
169,712 | Form 4 |
| 12 | Cassidy James Chief Medical Officer |
2025-01-14 16:31:36 | 132,346 0 |
132,346 | Form 4 |
| 13 | Pichl Daniel Chief People Officer |
2025-02-12 20:01:39 | 114,762 0 |
114,762 | Form 4 |
| 14 | Perier Francis I Jr Chief Financial Officer |
2025-01-14 16:36:52 | 95,308 0 |
95,308 | Form 4 |
| 15 | Weinstein Herschel S General Counsel & Secretary |
2025-01-14 16:39:01 | 90,670 0 |
90,670 | Form 4 |
| 16 | LYNCH DANIEL Director |
2025-02-24 18:57:12 | 82,944 0 |
82,944 | Form 4 |
| 17 | Ashar Bhavesh Chief Commercial Officer |
2025-02-24 18:58:02 | 62,053 0 |
62,053 | Form 4 |
| 18 | Lin Tai-An Chief Scientific Officer |
2025-01-14 16:34:43 | 53,285 0 |
53,285 | Form 4 |
| 19 | Nofi Michael Chief Accounting Officer |
2025-01-14 16:35:46 | 50,869 0 |
50,869 | Form 4 |
| 20 | Burgess Michael F. Head of Research & Development |
2022-07-20 18:02:22 | 49,584 0 |
49,584 | Form 4 |
| 21 | MACKAY MARTIN Director |
2024-07-30 16:10:34 | 39,408 0 |
39,408 | Form 4 |
| 22 | ALBAN CARLOS Director |
2024-05-17 16:01:41 | 31,017 0 |
31,017 | Form 4 |
| 23 | Fuhrman Alan Director |
2024-05-17 16:03:02 | 26,883 0 |
26,883 | Form 4 |
| 24 | Lewis-Hall Freda C Director |
2024-05-17 16:06:11 | 26,883 0 |
26,883 | Form 4 |
| 25 | Hambleton Julie Director |
2025-02-12 19:57:25 | 4,095 0 |
4,095 | Form 4 |
| 26 | PATRICK DEVAL L Director |
2019-09-12 16:36:08 | 0 0 |
0 | Form 3 |